Does THIOTEPA Cause Plasma cell myeloma refractory? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Plasma cell myeloma refractory have been filed in association with THIOTEPA (Thiotepa). This represents 0.2% of all adverse event reports for THIOTEPA.
13
Reports of Plasma cell myeloma refractory with THIOTEPA
0.2%
of all THIOTEPA reports
0
Deaths
6
Hospitalizations
How Dangerous Is Plasma cell myeloma refractory From THIOTEPA?
Of the 13 reports, 6 (46.2%) required hospitalization.
Is Plasma cell myeloma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THIOTEPA. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does THIOTEPA Cause?
Off label use (762)
Febrile neutropenia (645)
Mucosal inflammation (616)
Cytomegalovirus infection (446)
Product use in unapproved indication (425)
Pyrexia (359)
Drug ineffective (358)
Acute graft versus host disease in skin (355)
Acute graft versus host disease (331)
Cytomegalovirus infection reactivation (325)
What Other Drugs Cause Plasma cell myeloma refractory?
BORTEZOMIB (618)
DEXAMETHASONE (513)
LENALIDOMIDE (489)
DARATUMUMAB (404)
CARFILZOMIB (386)
POMALIDOMIDE (280)
CYCLOPHOSPHAMIDE (237)
IXAZOMIB (132)
DOXORUBICIN (115)
ETOPOSIDE (90)
Which THIOTEPA Alternatives Have Lower Plasma cell myeloma refractory Risk?
THIOTEPA vs THIOTHIXENE
THIOTEPA vs THROMBIN
THIOTEPA vs THROMBIN HUMAN
THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS
THIOTEPA vs THYMOGLOBULINE